目的:觀察纈沙坦逆轉(zhuǎn)輕中度原發(fā)性高血壓左室肥厚的療效。方法:采用自身對照試驗, 116 例輕中度原發(fā)性高血壓伴左室肥厚的患者, 服用纈沙坦80~160mg/d, 共36 周, 隨訪患者血壓、超聲心動圖及不良反應。結(jié)果: 116例患者治療后血壓明顯下降(P lt;0.05), 左心室舒末內(nèi)徑(LVDd)、室間隔厚度(IVST) 、心室后壁厚度(PWT) 、左室重指數(shù)(LVMI) 均明顯減少 (P 均 lt;0.01),無明顯不良反應。結(jié)論: 纈沙坦治療輕中度原發(fā)性高血壓療效確切, 有效逆轉(zhuǎn)左室肥厚。
引用本文: 吳鏡,蔡琳,王偉,唐炯,羅俊,燕純伯,鄧曉奇. 纈沙坦逆轉(zhuǎn)輕中度原發(fā)性高血壓左心室肥厚療效觀察. 華西醫(yī)學, 2009, 24(7): 1818-1820. doi: 復制
版權(quán)信息: ?四川大學華西醫(yī)院華西期刊社《華西醫(yī)學》版權(quán)所有,未經(jīng)授權(quán)不得轉(zhuǎn)載、改編
1. | |
2. | 英俊岐, 王歆月, 濮蓉暉, 等. 高血壓左室肥厚形成及其逆轉(zhuǎn)研究進展[J]. 醫(yī)學綜述, 2003, 9 (12): 738-740.. |
3. | 許智韜, 王瑋, 田青, 等. 高血壓患者左心室肥厚與QT離散度增大[J]. 中華心律失常雜志, 2000, 4: 276-277.. |
4. | LEENEN FHH. Left ventricular hypertrophy in patients [J]. Am J Med, 1989, 86 (IB): 63-67.. |
5. | 劉力生. 中國高血壓防治指南[M]. 北京: 人民衛(wèi)生出版社,2005: 14.. |
6. | CIRCULATION. 2009,119(4):524-9.. |
7. | MED PREGL.2008,61(7-8):369-374.. |
8. | 丁國峰, 孫運愛, 武金蓮, 等. 氨氯地平治療高血壓及逆轉(zhuǎn)左室肥厚作用的臨床研究[J]. 心血管康復醫(yī)學雜志, 2004, 13(2): 163-165.. |
9. | BRAZ NOGUEIRA J. Regression of left ventricular hypertrophy in hypertensiondoes it reduce cardiovascular risk? [J]. Rev Port Cardiol, 2005, 24 (728): 1007-1013.. |
10. | OKIN PM, DEVEREUX RB, JERN S, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatmentand the prediction of major cardiovascular events[ J ]. JAMA, 2004,292 (19): 2343-2349. |
11. | CONRADY AO, RUDOMANOV OG, ZAHAROV DV, et al. Prospective study of the changes in left ventricularmass and geometry patterns in hypertensive patients During 5 years of followup [ J ]. Circ J, 2005, 69(11): 1374-1379.. |
12. | DEVEREUX RB. Therapeutic options in minimizing left ventricular hypertrophy [ J ]. Am Heart J, 2000,139: 9.. |
13. | NIPPON RINSHO.2009,67(4):723-8.. |
14. | 陳文彬,羅德成,主編. 臨床藥物治療學[M]. 北京:人民衛(wèi)生出版社,2004:107.. |
15. | CALIFF RM, COHN JN, MINM M. Cardiac protection: Evolving role of angiotensin receptor blockers [ J ]. Am Heart J, 2000, 139: 15.. |
- 1.
- 2. 英俊岐, 王歆月, 濮蓉暉, 等. 高血壓左室肥厚形成及其逆轉(zhuǎn)研究進展[J]. 醫(yī)學綜述, 2003, 9 (12): 738-740..
- 3. 許智韜, 王瑋, 田青, 等. 高血壓患者左心室肥厚與QT離散度增大[J]. 中華心律失常雜志, 2000, 4: 276-277..
- 4. LEENEN FHH. Left ventricular hypertrophy in patients [J]. Am J Med, 1989, 86 (IB): 63-67..
- 5. 劉力生. 中國高血壓防治指南[M]. 北京: 人民衛(wèi)生出版社,2005: 14..
- 6. CIRCULATION. 2009,119(4):524-9..
- 7. MED PREGL.2008,61(7-8):369-374..
- 8. 丁國峰, 孫運愛, 武金蓮, 等. 氨氯地平治療高血壓及逆轉(zhuǎn)左室肥厚作用的臨床研究[J]. 心血管康復醫(yī)學雜志, 2004, 13(2): 163-165..
- 9. BRAZ NOGUEIRA J. Regression of left ventricular hypertrophy in hypertensiondoes it reduce cardiovascular risk? [J]. Rev Port Cardiol, 2005, 24 (728): 1007-1013..
- 10. OKIN PM, DEVEREUX RB, JERN S, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatmentand the prediction of major cardiovascular events[ J ]. JAMA, 2004,292 (19): 2343-2349.
- 11. CONRADY AO, RUDOMANOV OG, ZAHAROV DV, et al. Prospective study of the changes in left ventricularmass and geometry patterns in hypertensive patients During 5 years of followup [ J ]. Circ J, 2005, 69(11): 1374-1379..
- 12. DEVEREUX RB. Therapeutic options in minimizing left ventricular hypertrophy [ J ]. Am Heart J, 2000,139: 9..
- 13. NIPPON RINSHO.2009,67(4):723-8..
- 14. 陳文彬,羅德成,主編. 臨床藥物治療學[M]. 北京:人民衛(wèi)生出版社,2004:107..
- 15. CALIFF RM, COHN JN, MINM M. Cardiac protection: Evolving role of angiotensin receptor blockers [ J ]. Am Heart J, 2000, 139: 15..